Managing immune-mediated hemolytic anemia

摘要

Immune-mediated hemolytic anemia (IMHA) is far from a simple disease with a straightforward treatment plan. Difficult to treat and confusing to manage over time, this disease has many clinicians referring patients to internists for both short- and long-term management. The difficulties may be due largely to the fact that each patient is so different in how they present, how the disease progresses.